Pericranial Muscle Stiffness, Pain Thresholds, and Tenderness during a Treatment Cycle of OnabotulinumtoxinA for Chronic Migraine Prevention.
Sebastian Worsaae DalbyJeppe HvedstrupLouise Ninett CarlsenSait AshinaLars BendtsenHenrik Winther SchytzPublished in: Diagnostics (Basel, Switzerland) (2024)
The findings suggest that BoNT-A leads to the desensitization of cutaneous and muscle nociceptors in the head and neck regions, whereas muscle relaxation might not be an important part of the anti-migraine effect.